Search results for “BRAF V600E” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 56 patents, we discovered top 26 key players by total patent application. Response Genetics, Inc., German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Novartis AG are dominant in this area. They take 39.29% of the total patent filing.
Response Genetics, Inc.
California, United States
Patent: 10
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Germany
Patent: 7
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Agilent Technologies, Inc.
Beijing Shi, China
Patent: 2
Toyo Kohan Co., Ltd.
Tokyo-to, Japan
Patent: 2
Anlong Gene Technology Co., Ltd.
Anhui Sheng, China
Patent: 2
Eli Lilly & Co.
Indiana, United States
Patent: 1
Genentech, Inc.
California, United States
Patent: 1
Cancer Genetics, Inc.
New Jersey, United States
Patent: 1
The Board of Regents of The University of Texas System
Texas, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Guangzhou Mygene Genetics Co. Ltd.
Guangdong Sheng, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 28 patents applied in the last 5 years. We discover 20 most active companies in this area. The fast-growing Memorial Sloan Kettering Cancer Center, The Johns Hopkins University, Novartis AG take 25.00% of patent filing during this period.
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 3
The Johns Hopkins University
United States
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
Toyo Kohan Co., Ltd.
Tokyo-to, Japan
Patent: 2
Agilent Technologies, Inc.
Beijing Shi, China
Patent: 2
Shanghai Rigen Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 1
Nanjing Kinomi Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Yuanchen Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Hangzhou Ruipu Gene Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Zhejiang Cancer Hospital
Zhejiang Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 28 patents in last 5 years, we discover 17 new entrants. Toyo Kohan Co., Ltd., Agilent Technologies, Inc., Shanghai Rigen Biotechnology Co. Ltd. are the most active new entrants in this area.
Toyo Kohan Co., Ltd.
Tokyo-to, Japan
Patent: 2
Agilent Technologies, Inc.
Beijing Shi, China
Patent: 2
Shanghai Rigen Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 1
Nanjing Kinomi Medical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Yuanchen Biotechnology (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Hangzhou Ruipu Gene Technology Co., Ltd.
Zhejiang Sheng, China
Patent: 1
Zhejiang Cancer Hospital
Zhejiang Sheng, China
Patent: 1
Shanghai Dage Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 1
Chongqing Medical University
Chongqing Shi, China
Patent: 1
Qingdao Puze Med Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 25 patents, we discovered top 4 universities and scientific research institutions by total patent application. Ruprecht-Karls-Universität Heidelberg, The Johns Hopkins University, Chongqing Medical University are dominant in this area. They take 88.00% of the total patent filing.
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 5
The Johns Hopkins University
United States
Patent: 4
Chongqing Medical University
Chongqing Shi, China
Patent: 1
Qingdao University
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: